Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $20.6 million.

  • NeuroPace's Cash & Equivalents rose 3392.14% to $20.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 3392.14%. This contributed to the annual value of $13.4 million for FY2024, which is 2562.85% down from last year.
  • Per NeuroPace's latest filing, its Cash & Equivalents stood at $20.6 million for Q3 2025, which was up 3392.14% from $22.9 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Cash & Equivalents registered a high of $31.2 million during Q2 2021, and its lowest value of $5.7 million during Q3 2022.
  • For the 5-year period, NeuroPace's Cash & Equivalents averaged around $14.9 million, with its median value being $13.4 million (2024).
  • Per our database at Business Quant, NeuroPace's Cash & Equivalents skyrocketed by 21250.13% in 2021 and then crashed by 8175.18% in 2022.
  • Over the past 5 years, NeuroPace's Cash & Equivalents (Quarter) stood at $19.2 million in 2021, then tumbled by 65.58% to $6.6 million in 2022, then surged by 173.4% to $18.1 million in 2023, then decreased by 25.63% to $13.4 million in 2024, then surged by 53.75% to $20.6 million in 2025.
  • Its last three reported values are $20.6 million in Q3 2025, $22.9 million for Q2 2025, and $27.0 million during Q1 2025.